Delivery Order SPE2DB25D3109-SPE2DB25FPKUW
Award Date 7/21/25
Potential Completion Date 7/22/25
Potential Value $19K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor, AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $4,928.58 firm fixed price order is for the supply of GEMTESA 75 MG TABLET 30S, a pharmaceutical product. The contract has a completion date of December 28, 2023. No set-aside designation was used. AmerisourceBergen Drug Corp has an established track record of providing pharmaceutical products and...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the provision of 30-count packages of the drug GEMTESA 75 MG TABLET. The contract has a ceiling value of $2,118.59 and a completion date of July 2, 2025. It is not set aside for any special designation. The contract is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA,...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a total ceiling value of $4,562.81. The contract has an ultimate completion date of May 19, 2025. This order is not set aside and is awarded as part of a larger Indefinite Delivery Contract (IDC) worth...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of GEMTESA 75 MG TABLET 30S, a prescription medication, with a ceiling value of $3,088.16 and a performance period ending on May 22, 2025. The contract is a Firm Fixed Price (FFP) delivery order, without a set-aside designation, indicating open competition. Amerisourcebergen...
- This federal contract award, with identification number SPE2DX15D3005|SPE2DX24F3PGF, was granted by the Defense Logistics Agency (DLA) Troop Support Medical to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $27,360.83 and a completion date of February 5, 2024. The award is not designated as a set-aside contract and is instead awarded through full and...
- This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,982.14, is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of July 2, 2025. This delivery order is associated with a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued...
- This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of GEMTESA 75 MG TABLET 30S. The contract has a ceiling value of $1,703.29 and will run through September 24, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, which enables the government to...
- This federal contract award, with ID SPE2DB20D2104|SPE2DB25FMCMM, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of GEMTESA 75 MG TABLET 90S, a pharmaceutical product, with a ceiling value of $12,878.49. The contract type is a Delivery Order with a Firm Fixed Price pricing structure, and the ultimate completion date is November 21, 2024. The contract is not...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The $7,986.85 firm fixed price contract is for the supply of GEMTESA 75 MG TABLET 90S, a prescription medication. The award does not have a set-aside designation. The delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999 through December 2025, that enables the government to efficiently...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4565535775 GEMTESA 75 MG TABLET 90S. The order has a ceiling value of $12,198.09 and is a firm-fixed-price contract. The work is to be performed in Conshohocken, PA and the ultimate completion date is August 22, 2024. This order is not associated with a set-aside program. AmerisourceBergen, through its extensive pharmaceutical distribution...
- SPE2DB25D3109Indefinite Delivery Contract
- SPE2DB25D3109-SPE2DB25FPKUWDelivery Order
4568853014 ! GEMTESA 75 MG TABLET 30S
Posted 7/21/25
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $18.8k | 7/21/25 |